EIHSX Holdings — Eaton Vance Worldwide Health Sciences Fund
All 42 reported holdings of Eaton Vance Worldwide Health Sciences Fund (EIHSX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 12.47% | $94.53M |
| AbbVie Inc | 6.46% | $48.92M |
| Johnson & Johnson | 6.45% | $48.85M |
| AstraZeneca PLC | 6.24% | $47.32M |
| UnitedHealth Group Inc | 5.49% | $41.59M |
| Roche Holding AG | 5.44% | $41.24M |
| Merck & Co Inc | 5.08% | $38.49M |
| Bristol-Myers Squibb Co | 4.25% | $32.23M |
| Vertex Pharmaceuticals Inc | 3.38% | $25.64M |
| Gilead Sciences Inc | 3.34% | $25.32M |
| Sanofi SA | 2.95% | $22.34M |
| Thermo Fisher Scientific Inc | 2.79% | $21.18M |
| Intuitive Surgical Inc | 2.72% | $20.59M |
| Stryker Corp | 2.21% | $16.76M |
| Boston Scientific Corp | 2.18% | $16.50M |
| Medtronic PLC | 1.80% | $13.66M |
| Lonza Group AG | 1.77% | $13.42M |
| Novo Nordisk A/S | 1.71% | $12.96M |
| Abbott Laboratories | 1.65% | $12.51M |
| Novartis AG | 1.65% | $12.50M |
| Argenx SE | 1.61% | $12.21M |
| Royalty Pharma PLC | 1.58% | $12.01M |
| Neurocrine Biosciences Inc | 1.41% | $10.67M |
| Mettler-Toledo International Inc | 1.36% | $10.31M |
| Straumann Holding AG | 1.34% | $10.15M |
| Quest Diagnostics Inc | 1.30% | $9.83M |
| Genmab A/S | 1.20% | $9.06M |
| Edwards Lifesciences Corp | 1.17% | $8.87M |
| Zoetis Inc | 1.12% | $8.50M |
| Cooper Cos Inc/The | 1.04% | $7.85M |
| CSL Ltd | 0.91% | $6.88M |
| HeartFlow Inc | 0.90% | $6.78M |
| Danaher Corp | 0.89% | $6.77M |
| Recordati Industria Chimica e Farmaceutica SpA | 0.73% | $5.51M |
| Xenon Pharmaceuticals Inc | 0.72% | $5.48M |
| Generate Biomedicines Inc | 0.54% | $4.10M |
| Apogee Therapeutics Inc | 0.36% | $2.76M |
| Newamsterdam Pharma Co NV | 0.36% | $2.75M |
| Morgan Stanley & Co. LLC | 0.31% | $2.32M |
| Caris Life Sciences Inc | 0.30% | $2.27M |
| EssilorLuxottica SA | 0.28% | $2.15M |
| MBX Biosciences Inc | 0.25% | $1.88M |
EIHSX overview: performance, fees, allocation and SEC filings